Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
02/1989
02/28/1989US4808701 Cyclic peptides having appetite regulating activity
02/28/1989US4808700 Vaccine for immunization of young mammals against infections
02/28/1989US4808573 Angiotensin converting enzyme inhibitors
02/28/1989US4808572 α-Hydroxy thioethers
02/28/1989US4808314 Method for reducing bacterial endotoxin contamination in solutions of macromolecules
02/28/1989CA1250700A1 Glycopeptide derivatives
02/23/1989WO1989001492A1 Novel polypeptide and method for preparing the same
02/23/1989WO1989001487A1 Removal of n-terminal acylated amino acid residues from polypeptides
02/23/1989WO1989001485A1 Purification of raw peptides by preparative medium-pressure liquid chromatography
02/23/1989WO1989001484A1 Process for intramolecular oxidation of two -sh groups in a peptide compound to a disulphide bridge, and peptide so obtained
02/23/1989WO1989001343A1 Cationized antibodies for delivery through the blood-brain barrier
02/23/1989WO1989001335A1 Biospecific polymers
02/23/1989WO1989000582A3 Human granulocyte-macrophage colony stimulating factor and muteins thereof
02/22/1989EP0304311A1 Complex of polyethylene glycol and tissue plasminogen activator
02/22/1989EP0304292A2 Antibody to propeptide of procollagen type III, and assay method using it
02/22/1989EP0303602A1 Enzymatic synthesis
02/21/1989US4806641 Salts of 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine and amino compounds
02/21/1989US4806626 α-amylase inhibitor
02/21/1989US4806492 Polypeptide tumor inhibitors and antibodies thereto
02/21/1989US4806473 Using carboxypeptidase y to cleave protective groups; producing di-, tri- and tetrapeptides
02/21/1989US4806343 Cryogenic protectant for proteins
02/21/1989US4806336 Human intestinal hormone and its use
02/21/1989CA1250399A1 Peptide synthesis process
02/21/1989CA1250398A1 Tri-tetra- and pentapeptides, their preparation, and pharmaceutical products containing same
02/15/1989EP0303538A2 Protein with a vascular activity, derived from monocytes and its analogues, process for its extraction and their uses as therapeutic agents and for the preparation of antibodies
02/15/1989EP0303329A1 A process for isolating coagulation factors, and adsorbent material suitable therefor
02/15/1989EP0303224A2 Crystallization device
02/15/1989EP0303088A2 Purified IgM
02/15/1989EP0303033A2 Molecular cloning and characterization of a further gene sequence coding for human relaxin
02/15/1989EP0303028A1 Method for preparing single chain urokinase
02/15/1989EP0302928A1 Inorganic filtration membrane modified for protein separation.
02/15/1989EP0302925A1 A method for producing factor viii in high yield
02/15/1989EP0302892A1 Segmented polypeptide bioeleastomers to modulate elastic modulus.
02/14/1989CA1250098A1 Ester derivatives of antibiotic l 17046
02/14/1989CA1250097A1 Process for preparing antibiotic l 17046
02/14/1989CA1250096A1 Process for preparing antibiotic l 17392 (deglucoteicoplanin)
02/14/1989CA1250095A1 Carboxylic acid ester derivatives of deglucoteicoplanin
02/14/1989CA1250094A1 Chemical process for preparing antibiotic l 17054
02/14/1989CA1249975A1 Non-radioactive biological probes
02/09/1989WO1989001046A1 Purification of human interleukin-4 expressed in escherichia coli
02/09/1989WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
02/09/1989WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents
02/09/1989EP0204826A4 Heat stabilized peptide sweeteners.
02/08/1989EP0302734A2 Continuous processes for modifying biologically active materials and the products therefrom
02/08/1989EP0302503A2 Method for the separation and purification of t-PA
02/08/1989EP0302478A1 Method for purifying a dipeptide ester
02/08/1989EP0302469A2 Process for reactivating protein
02/08/1989EP0302407A2 Metallic complexes of streptogramin-B, their preparation and their use in animal food
02/08/1989EP0169111B1 Cytotoxic conjugates useful in therapy, and process for obtaining them
02/08/1989CN1030917A Immunosuppressant peptides
02/07/1989US4803300 Crystallization; sterioisomers
02/07/1989US4803261 Method for synthesizing a peptide containing a non-peptide
02/07/1989CA1249811A1 Rigid coupling compounds
02/01/1989EP0301970A1 Method for dissolving arginineamides and pharmaceutical compositions containing them
02/01/1989EP0301835A1 Purification of human interleukin-4 expressed in Escherichia Coli
02/01/1989EP0301785A2 Carboxamide derivatives of glycopeptides
02/01/1989EP0301639A2 Analogues of the bradykinin potentiating peptide BPP 5a and methods for their preparation
02/01/1989EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH
02/01/1989EP0301398A2 Process for producing N-[(4-hydroxy-pyrrolidin-2-on-1-yl)-acetyl]-glycinamide
02/01/1989EP0301374A2 Process for the purification of the placenta tissue protein PP4
02/01/1989CN1030766A Enkastine-glycopeptide of action having inhibitory encephalinase, process for preparing them and pharamaceutical use
02/01/1989CN1030748A Vinyl substituted radiohalogen conjugates for protein labeling
01/1989
01/31/1989US4801721 Stereospecific synthesis of carboxyalkyl peptides
01/31/1989US4801691 Precipitation with guanidine hydrochloride
01/31/1989US4801689 Isolation from mammalian oxiduct, absorption onto lecithin immobilized on support, then separation
01/31/1989US4801687 Monoclonal antibody purification process using protein A
01/31/1989US4801686 Suspension, microbial cells, breaking, extraction
01/31/1989US4801684 Process for obtaining insulin precursors from reaction mixtures resulting from the folding of insulin precursors from the corresponding S-sulfonates
01/31/1989US4801665 Resin method for making sulfoxide for solid phase peptide synthesis
01/31/1989US4801579 Nutrient solutions, water solubility
01/31/1989US4801578 Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication
01/31/1989US4801577 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
01/31/1989US4801576 Polypeptides
01/31/1989US4801575 Chimeric peptides for neuropeptide delivery through the blood-brain barrier
01/31/1989CA1249698A1 Retro-inverso analogues of c-terminal penta and hexapeptides of substance p
01/26/1989WO1989000689A1 High resolution electrophoretic gel and method for separating serum proteins
01/26/1989WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof
01/26/1989WO1989000581A1 Lectines fixing beta-d-galactoside
01/26/1989WO1989000579A1 Purification of gm-csf
01/26/1989WO1989000446A1 Affinity separating using immobilized flocculating reagents
01/26/1989WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof
01/26/1989DE3723004A1 Apparatus for the simultaneous synthesis of a plurality of polypeptides
01/25/1989EP0300988A2 Tissue factor inhibitor
01/25/1989EP0300973A1 Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them
01/25/1989EP0300849A1 Process for the chemical modification of protides, and products so modified
01/25/1989EP0300741A2 Human thymopoietin
01/25/1989EP0300518A1 Guanidine compounds containing a tetraphenylborate-ion, process for obtaining these compounds and use of these compounds in peptide synthesis
01/25/1989EP0300450A2 Method for producing alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride
01/25/1989EP0300071A1 Process for the separation and purification of organic substances from impurities
01/25/1989EP0300001A1 Aminoluciferines, process for producing same and use thereof.
01/25/1989EP0299965A1 Antigenic analogues of platelet activating factor (paf)
01/25/1989CN1030589A Urinary follicle stimulating hormone
01/24/1989US4800191 Luteinizing hormone releasing hormone, peptides
01/24/1989US4800166 Method and apparatus for monitoring the automated synthesis of peptides
01/24/1989CA1249399A1 Process for preparing v.sub.1-vasopressin antagonists
01/24/1989CA1249398A1 Process for preparing basic v.sub.1-vasopressin antagonists
01/24/1989CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life
01/18/1989EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92)
01/18/1989EP0299746A1 Purification of GM-CSF
01/18/1989EP0299706A2 Nonglycosylated plasminogen activator and method of preparation